Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant
US 800-774-4410
or +1-240-747-3094
Search Assistance >

Home  > Healthcare  >  Biotechnology  >  Genetics & Genomics

Next Generation Sequencing for Life Science R&D: Advancing to the $1,000 Genome

Published Date: July 2008
Published By: Fuji-Keizai USA, Inc.
Page Count: 137
Order Code: R98-204
 
Questions About This Report
E-mail a Colleague
Printable Page
Fax Your Order
DescriptionTable of ContentsSimilar
Products

Executive Summary
1. Overview of the Genome Sequencing Market for R&D
1.1 Overview of Current and Next-Generation Genome Sequencing for R&D
Figure 1. The Next-Generation Genome Sequencing Market Landscape
1.1.2 Genome Sequencing Equipment Systems
Current Sanger-based CE Sequencing Systems
Next-Generation Sequencing Systems (Commercial)
Next-Generation Sequencing Systems (In Development)
1.1.3 Bioinformatics Software
Table 1. Sequencer Vendor Provided Software(Source, NG Seq. Platform, Name)
Table 2. Selected Commercial Software (Source, Name, Comment)
Table 3. Selected Open Source Short-Read Assembly Software (Source, Name, Comment)
1.1.4 Genome Sequencing Organizations
Academic Genome Sequencing Centers
Academic/ Government Core Labs
Commercial Service Providers
1.1.5 IT Infrastructure and Applications
IT Infrastructure Vendors and Solutions
1.1.6 Others
1.2 Next-Gen. Genome Sequencing Applications & Projects for R&D
1.2.1 Academic Life Science Applications
1.2.2 Pharma/ Biotech Drug Discovery R&D
1.2.3 Clinical Diagnostic Applications and Projects
1.2.4 Public Health Applications
1.2.5 Emerging ‘Consumer Genomics’ Applications
1.2.6 Agricultural/ Veterinary Applications
1.2.7 Environmental (Metagenomics) Applications
1.2.8 Other Related Applications
2. Next-Gen. Genome Sequencing Technology Developments
2.1 Government and Private Next-Generation DNA Sequencing Initiatives
2.1.1 The NIH’s 2004 Proposal for Sequencing the Genome for $1,000
Table 4. Next-Generation Sequencing Tech. Grants Awarded by NHGRI 2004-2007 (Grant Year, Grant Goal, Organization, Next-Gen.Sequencing Technology Development Grants, Grant Amount, Term (Yr), Teams)
2.1.2 The $10 Million Archon X PRIZE for Genomics
Table 5. Competing Teams for the X PRIZE for Genomics
2.2 Developing Technologies for the Next Five-Years and Beyond
2.2.1 Near-Term Time Line Goal
2.2.2 $1,000 Genome Time Line Goal
2.3 Sequencing Technologies for the $100,000 Genome
Sample Preparation
Sequencing
Image Analysis
2.3.1 Roche/ 454 Life Sciences, Inc. GS FLX and XLR
Massively Parallel Sequencing by Synthesis (Pyrosequencing)
Figure 2. Roche/ 454 GS FLX DNA Sequencer
2.3.2 Illumina, Inc. Genome Analyzer II - Sequencing by Synthesis
Figure 3. Illumina Genome Analyzer
2.3.3 Applied Biosystems Inc. SOLiD - Polony Sequencing by Ligation
Figure 4. The ABI SOLiD Sequencing
2.3.4 Danaher Motion Polonator G.007 - Open Source Polony Sequencing System
Figure 5. The Danaher-Church Polonator G.007
2.3.5 Helicos BioSciences Inc. HeliScope - Single-Molecule Sequencing
Figure 6. Helicos HeliScope Sequencer
2.4 Sequencing Technologies for $1,000 Genome
2.4.1 Pacific BioSciences, Inc. Real Time Single-Molecule Sequencing
Figure 7. Simultaneous & Continuous Excitation & Detection in a ZMW
2.4.2 ZS Genetics Direct Electron Microscope Sequencing
Figure 8. Overview of the ZSG Sequencing Process
3. Key Alliances, M&As and IP
3.1 Summary of Key Alliances and M&As
3.1.1 Definitions of Alliance and M&A Deal Types
M&As
Development and Supplier Partnerships
IP Licensing Agreements
3.1.2 Highlights of Key Alliances and M&As
Table 6. Summary of Key Alliances and M&As, Mar/2005 to Jun/2008
3.1.3 Data Tables for Alliances and M&As
Table 7. Key Alliances and M&As Jan to Jun 2008 (Date, Technology, Alliance Type, Buyer, Seller, Comment)
3.2 IP, Business Development and Challenges
3.2.1 Summary of Key Patents Involving Sequencing Technologies
Table 11. NGS Related US Patents Issued to Orgs., 2007 to May/2008
3.2.2 The Business Value of IP
Table 12. Key Acquisitions in Next-Generation Sequencing.(Acquirer, Target Company, Comment, Value $M)
3.2.3 IP Challenges
4. The Market and Outlook for Next-Generation Genome Sequencing
4.1 The Total Worldwide Market Size, 2007-2012
Figure 9. Total Next-Gen. Sequencing Tools & Service Market 2007-2012
Table 13. Total Next-Gen. Sequencing Tools & Service Market 2007-2012
4.2 Market Size by Products & Services
4.2.1 Methodology and Definitions
4.2.2 Next-Gen. Sequencing Tools & Service Market By Product & Service Segments
Figure 10. Next-Gen. Sequencing Tools & Service Market By Product & Service Segments2007-2012
Table 14. Next-Gen. Sequencing Tools & Service Market By Product & Service Segments 2007-2012
4.2.3 Next-Gen. Sequencing Tools & Service Market By Product & Service Segment Shares, 2008 & 2012
Figure 11. Next-Gen. Sequencing Tools & Service Market By Product & Service Segment Shares, 2008 & 2012
Table 15. WW Market by Major Segments & Shares, 2008 & 2012
Figure 12. Next-Gen. Sequencing Tools & Service Market By Application Segments
Table 16. Next-Gen. Sequencing Tools & Service Market By Application Segments
4.3 Market by Customer Segments
Table 17. Next-Gen. Sequencing Tools & Service Market By Customer Segments
Figure 13. Next-Gen. Sequencing Tools & Service Market By Customer Segments
4.4 Market by WW Regions
Figure 14. Next-Gen. Sequencing Tools & Service Market By WW Regions
Table 18. Next-Gen. Sequencing Tools & Service Market By WW Regions
5. Activities of the Firms Offering Next-Generation Genome Sequencing Products & Services
5.1 NG Seq. Commercial Equipment
5.1.1 - 5.1.4 (Total 4 companies)
A. Contact Information
B. Key Business Facts
C. Company Overview, Technology and Key Products
D. Alliances, Strategy, Mergers and Acquisitions
E. Patents, Milestones, Funding, and Other Findings
5.2 NG Seq. Equipment Developers
5.2.1 - 5.2.4 (Total 4 compnies)
Same as above-mentioned research items
5.3 Consumer Genomics Services
5.3.1 - 5.3.4 (Total 4 companies)
Same as above-mentioned research items
5.4 Contract Genomic Research Services
5.4.1 - 5.4.4 (Total 4 companies)
Same as above-mentioned research items
5.5 Software
5.5.1 (Total one company)
Same as above-mentioned research items
6. Conclusions and New Business Opportunities
6.1 Likely Next-Gen. Genome Sequencing Success and Failure Factors
6.1.1 The Human Genome Project Cost $3.5 Billion and 13 Years Effort
6.1.2 Advances in Technology Enable Emerging Next-Gen. Sequencers.
6.1.3 Government Technology Initiative - The $100, 000 and $1,000 Genomes
6.1.4 Private Technology Initiative - The X PRIZE for Genomics Fosters Race to Reach the $10,000 Genome
6.1.5 Key M&As Enabled Commercial Next-Gen. Sequencing Platforms
6.1.6 Barriers to Market Entry Are Getting More Challenging
6.1.7 Next-Generation Sequencers Output Enormous Amounts of Data
6.1.8 Consumers Want Their Personal Genomes
6.1.9 Known Individuals are Getting Their Genomes Sequenced
6.1.10 Government Regulators Jump In
6.2 Review of the Hot Development Areas in Next-Generation Genome Sequencing
6.2.1 Next-Generation Sequencing Systems May Replace CE Sequencing and Enable New Applications
Table 19. Applications Unique to Next-Generation Sequencers
6.2.2 Automated Sample Preparation
6.2.3 Microarray Capture Method Front-end for Targeted Sequencing
6.3 Large-Scale International Sequencing Projects Use Next-Generation Sequencing
6.3.1 Scientists Want to Sequence 100,000’s of Humans to Enable Personal Medicine
6.3.2 The 1,000 Genomes Project
6.3.3 Human Microbiome Project
6.3.4 The Cancer Genome Atlas (US)
6.3.5 The Wellcome Trust Sanger Institute’s Cancer Genome Project
6.3.6 The Yanhuang Project
6.4 Next-Generation Genome Sequencing Business Opportunities or Implications
6.4.1 Opportunities or Implications for the US
Table 20. Opportunities or Implications for the US(Region, Opportunity Area, Comment)
6.4.2 Opportunities or Implications for Europe
Table 21. Opportunities or Implications for Europe(Region, Opportunity Area, Comment)
6.4.3 Opportunities or Implications for Japan and Asia (Region, Opportunity Area, Comment)
7. Appendix
7.1 Glossary
7.2 Key Genome Sequencing Centers
Similar Products
• Biotechnology Sector
Published Nov 2009 by First Research, Inc.

• Dealmaking and Industry Outlook: Neurological Disease
Published Nov 2009 by Decision Resources

• Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published Oct 2009 by BioSeeker Group AB

• Plunkett's Health Care Technologies Overview 2010 (Summary)
Published Oct 2009 by Plunkett Research, Ltd.

• The Human Genome Sequencing Center at Baylor College of Medicine Relies on Quantum's StorNext Software for Data Management
Published Oct 2009 by IDC

• Three Alternative Scenarios Of The Future In Vitro Diagnostics Market 2009-2018
Published Oct 2009 by Venture Planning Group

• Preventive Healthcare Technologies, Products and Markets
Published Oct 2009 by BCC Research

• Transfection Life Science Dashboard™ Series 2
Published Oct 2009 by Percepta Associates, Inc.

• Genealogy Products and Services
Published Oct 2009 by Global Industry Analysts

• Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook
Published Oct 2009 by Business Insights



 

Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com